ID27728A - Komposisi-komposisi mukoadesif oral yang mengandung bahan-bahan aktif gastrointestinal - Google Patents

Komposisi-komposisi mukoadesif oral yang mengandung bahan-bahan aktif gastrointestinal

Info

Publication number
ID27728A
ID27728A IDW20010423A ID20010423A ID27728A ID 27728 A ID27728 A ID 27728A ID W20010423 A IDW20010423 A ID W20010423A ID 20010423 A ID20010423 A ID 20010423A ID 27728 A ID27728 A ID 27728A
Authority
ID
Indonesia
Prior art keywords
mukoadesif
oral
active ingredients
compositions containing
gastrointestinal active
Prior art date
Application number
IDW20010423A
Other languages
English (en)
Inventor
Douglas Joseph Dobrozsi
Todd Ehren Vienneau
Christopher Robert Mayer
Kishorkumar Jivanial Desai
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ID27728A publication Critical patent/ID27728A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20010423A 1998-08-24 1999-08-24 Komposisi-komposisi mukoadesif oral yang mengandung bahan-bahan aktif gastrointestinal ID27728A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9757698P 1998-08-24 1998-08-24

Publications (1)

Publication Number Publication Date
ID27728A true ID27728A (id) 2001-04-26

Family

ID=22264116

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010423A ID27728A (id) 1998-08-24 1999-08-24 Komposisi-komposisi mukoadesif oral yang mengandung bahan-bahan aktif gastrointestinal

Country Status (15)

Country Link
US (1) US20010016577A1 (id)
EP (1) EP1115378A1 (id)
JP (1) JP2002523352A (id)
KR (1) KR20010072463A (id)
CN (1) CN1313755A (id)
AU (1) AU5685299A (id)
BR (1) BR9913227A (id)
CA (1) CA2338688A1 (id)
CO (1) CO5140071A1 (id)
HU (1) HUP0103216A2 (id)
ID (1) ID27728A (id)
NO (1) NO20010833D0 (id)
PE (1) PE20000860A1 (id)
TR (1) TR200100629T2 (id)
WO (1) WO2000010527A1 (id)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801791B1 (fr) * 1999-12-03 2003-05-30 Elpronat Composition pour animaux contenant du salicylate de methyle
EP1474109B1 (en) * 2001-12-21 2010-08-25 Alcon, Inc. Use of synthetic inorganic nanoparticles as carriers for ophthalmic drugs
CA2500218A1 (en) * 2002-09-26 2004-04-08 Yamanouchi Pharmaceutical Co., Ltd. Drug absorptivity improving agent
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090131386A1 (en) * 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DK3354276T3 (da) 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
BR112012008087A2 (pt) * 2009-08-05 2016-03-01 Tyco Healthcare curativo de ferimento cirúrgico incorporando esferas de hidrogel conectadas tendo um eletrodo embutido naquele lugar
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions
CA2822227C (en) * 2010-12-23 2017-01-17 Colgate-Palmolive Company Fluid compositions comprising a structuring agent
HK1200706A1 (en) 2011-12-15 2015-08-14 Colgate-Palmolive Company Aqueous oral care compositions
US20140178456A1 (en) * 2012-08-30 2014-06-26 Udaya Sankar Devanaboyina Methods and compositions for treating type 2 diabetes and related conditions
MX349983B (es) 2012-12-03 2017-08-23 Colgate Palmolive Co Procesos de fabricacion para geles de fluido.
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
CA2943422C (en) * 2014-04-29 2020-03-10 The Procter & Gamble Company Bismuth-containing liquid pharmaceutical suspensions
CA2943420C (en) * 2014-04-29 2019-06-25 The Procter & Gamble Company Method for making bismuth-containing liquid pharmaceutical suspensions
EP3169374B1 (en) 2014-07-14 2022-01-05 University of Utah Research Foundation In situ solidifying complex coacervates and methods of making and using thereof
JP2017178881A (ja) * 2016-03-31 2017-10-05 小林製薬株式会社 経口組成物
JP6950312B2 (ja) * 2017-07-12 2021-10-13 ライオン株式会社 液体医薬組成物及び医薬品
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤
JP7410876B2 (ja) 2018-01-26 2024-01-10 フルイデックス メディカル テクノロジー，リミティッド ライアビリティ カンパニー 血管閉塞のためにその場凝固複合コアセルベートを使用する装置及び方法
WO2020084530A1 (en) 2018-10-24 2020-04-30 Ferring B.V. Mucoadhesive pharmaceutical compositions of corticosteroids
WO2026010400A1 (ko) * 2024-07-03 2026-01-08 (주)시지바이오 스프레이형 점착성 점막 창상피복재

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
WO1994020074A1 (en) * 1993-03-12 1994-09-15 The Procter & Gamble Company Adsorbate compositions

Also Published As

Publication number Publication date
TR200100629T2 (tr) 2001-07-23
HUP0103216A2 (hu) 2002-01-28
CA2338688A1 (en) 2000-03-02
AU5685299A (en) 2000-03-14
NO20010833L (no) 2001-02-19
JP2002523352A (ja) 2002-07-30
US20010016577A1 (en) 2001-08-23
KR20010072463A (ko) 2001-07-31
EP1115378A1 (en) 2001-07-18
CO5140071A1 (es) 2002-03-22
BR9913227A (pt) 2001-05-22
CN1313755A (zh) 2001-09-19
WO2000010527A1 (en) 2000-03-02
PE20000860A1 (es) 2000-09-11
NO20010833D0 (no) 2001-02-19

Similar Documents

Publication Publication Date Title
ID27728A (id) Komposisi-komposisi mukoadesif oral yang mengandung bahan-bahan aktif gastrointestinal
ID26088A (id) Komposisi-komposisi sampo yang mengandung silikon
DK0943331T3 (da) Formuleringer indeholdende oxaliplatin
ID26720A (id) Komposisi oral
DE69807756D1 (de) Fotopolymerisierbare dentalzusammensetzungen
EG23943A (en) Flash-melt oral dosage formulation
DE69932177D1 (de) Dentalbleichzusammensetzung
EP1196147A4 (en) BUILDING COMPOSITIONS
HUP0103388A3 (en) Oral liquid mucoadhesive compositions
IL157741A0 (en) Pharmaceutical compositions containing an antihyperplastic active agent
HUP0202495A3 (en) Stable medicinal compositions for oral use
NO20004721D0 (no) Bruseformuleringer
AU2001283354A1 (en) Compositions containing hypoglycemically active stilbenoids
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
ATE311887T1 (de) Diphosphonsäure enthaltende zusammensetzungen
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
NO20012265D0 (no) Dispergerbare blandinger inneholdende L-DOPA-etylester
NO993096D0 (no) Orale cyklosporinformuleringer
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
AU2001216543A1 (en) Dental care compositions
ITMI991826A0 (it) Nuova formulazione orale
ATE357237T1 (de) Formulierungen enthaltend cefuroxim-axetil
AU2001268131A1 (en) Stabilized compositions containing oxygen-labile active agents
ID23429A (id) Komposisi-komposisi sertralina yang larut
AU2422699A (en) Oral care compositions